INSTITUTE OF MICROBIAL
TECHNOLOGY (IMTECH)
MANDATE
- To promote an
integrated research, development and design base for microbial technology.
- To undertake
basic and applied research and development programmes in established and
newly emerging areas of biotechnology including genetic engineering.
- To develop and
maintain gene pool resources and genetic stocks of microbial cultures andother
cell lines.
- To impart training
in microbiology, microbial technology and biochemical engineering to research
workers and technologists.To establish and maintain efectives linkages
with industry and educational institutions, develop capabilities for producing
design and engineering packages for industrial plants and to undertake
contract work on research and development in the area of biotechnology.
MAIN FACILITIES
- Scanning &
transmission electron microscopes.
- Ultra and super
speed centrifuges.
- HPLC/FPLC and
gas chromatograph.
- Amino acid analyser.
- Protein sequencer
and protein synthesizer.Fermentation pilot plant (1500 litre) and associated
down stream processing equipment.
- Alpha digital
computer system.
- Modern facilities
for identification, preservation and maintenance of microorganisms.
SIGNIFICANT
ACHIEVEMENTS
- Development
of a process for the efficient conversion of molasses to alcohol using
an osmo-tolerant and ethanol tolerant strain of yeast.
- Development
of know how for enzymatic conversion of rifamycin B to difamycin S.
- development
of simplified processes for purification of urokinase from urine, based
on anti-urokinase monoclonal antibodies.
- Development
of new targeting rationale for selective delivery of drugs to microphages
utilizing the exquisite specificity and high effciency of the process of
endocytosis mediated by receptors present exclusively on the cells of microphage
lineage. This provides a generalized method for manipulating the metabolical
activity of microphages for a variety of purposes and is likely
to find application in the application of therapy of diseases in which
macrophages are involved such as leishmaniasis, tuberculosis, leprosy,
rheumotoid arthritis as well as some neoplastic diseases.
- Identification
of a 150 kDa molocule on the macrophage surface and three molecules (155
kDa, 105 kDa and 37 kDa) on the b-lymphocyte surface as a novel costimulatory
molecules which slelectively activate TH1 & TH-2 cells respectively.
- Established
the clonality of V, cholerae 0139 strain and predicted that the
new epedemic strain 0139 for cholera has evolved from 01El Tor strain.
ACTING DIRECTOR
Dr P. R. Patnaik
CONTACT ADDRESS
Sector 39-A, Chandigarh.
160 014.
Telephone: (091)172-690908,
690713, 690785, 690263.
Telegram : INTECH,
CHANDIGARH.
Telex
: 0395-7369 IMT IN.
E-mail
: root@imtech.ernrt.in.
Copyright(c) Institute
of Microbial Technology, Chandigarh, 1997.
Created and Hosted
by NIO, Goa.